x
Filter:
Filters applied
- Pathway of the Month
- Byers, Lauren AverettRemove Byers, Lauren Averett filter
- Levin, Pavel ARemove Levin, Pavel A filter
- Journal of Thoracic OncologyRemove Journal of Thoracic Oncology filter
Pathway of the Month
1 Results
- Pathway of the MonthOpen Archive
Axl Receptor Axis: A New Therapeutic Target in Lung Cancer
Journal of Thoracic OncologyVol. 11Issue 8p1357–1362Published online: April 26, 2016- Pavel A. Levin
- Rolf A. Brekken
- Lauren Averett Byers
- John V. Heymach
- David E. Gerber
Cited in Scopus: 29Axl belongs to the TAM family of receptor tyrosine kinases, which consists of Tyro3, Axl, and Mer. All three family members have similar structures and share a number of ligands, including the vitamin K–dependent ligands growth arrest protein 6 (Gas6) and protein S. In normal tissues, TAM receptor tyrosine kinases contribute to immune response regulation, including clearance of apoptotic cells and inhibition of cytotoxic immune activation in response to apoptosis. When cells undergo apoptosis, the polarity of the plasma membrane lipid bilayer is altered, externalizing the anionic phospholipid phosphatidylserine (PS).